The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study

Clinical trial NCT00452556 · UNKNOWN

Trial details

NCT number: NCT00452556
Sponsor: Nova Scotia Cancer Centre
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2007-05-01
Primary completion: 2017-02-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.